Managing Menopausal Symptoms

Handbook of Models for Human Aging

Volumn , Issue , 2006, Pages 873-879

  Rousseau, Mary Ellen ^a  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952315164     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369391-4/50074-6     Document Type: Chapter

References (43)

1. N.E. Avis, P.A. Kaufert, M. Lock, S.M. McKinlay and K. Vass (1993) The evolution of menopausal symptoms. Baillieres Clinical Endocrinology and Metabolism 7(1), 17-32.
2. N.E. Avis, R. Stellato, S. Crawford, J. Bromberger, P. Ganz, V. Cain, et al. (2001) Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Social Science and Medicine 52(3), 345-356.
3. R.J. Baber, C. Templeman, T. Morton, G.E. Kelly and L. West (1999) Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 2(2), 85-92.
4. M.G. Bergmans, J.M. Merkus, R.S. Corbey, L.A. Schellekens and J.M. Ubachs (1987) Effect of Bellergal Retard on climacteric complaints: A double-blind, placebo-controlled study. Maturitas 9(3), 227-234.
5. J.S. Carpenter and J.G. Neal (2005) Other complementary and alternative medicine modalities: Acupuncture, magnets, reflexology and homeopathy. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms March 21–25, 2005, Bethesda, MD
6. L. Dennerstein (2005) Sexuality. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms March 21–25, 2005, Bethesda, MD
7. L. Dennerstein, E.C. Dudley and J.R. Guthrie (2003) Predictors of declining self-rated health during the transition to menopause. Journal of Psychosomatic Research 54(2), 147-153.
8. L. Dennerstein, J. Randolph, J. Taffe, E. Dudley and H. Burger (2002) Hormones, mood, sexuality, and the menopausal transition. Fertility and Sterility 77(Suppl 4), S42-S48.
9. D.M. Eisenberg, R.B. Davis and S.L. Ettner (1998) Trends in alternative medicine use in the US, 1990–1997: Results of a follow-up survey. JAMA 280(18), 1569-1575.
10. B. Ettinger, D. Grady, A.N. Tosteson, A. Pressman and J.L. Macer (2003) Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstetrics and Gynecology 102(6), 1225-1232.
11. E.D. Faure, P. Chantre and P. Mares (2002) Effects of a standardized soy extract on hot flushes: A multicenter, double-blind, randomized, placebo-controlled study. Menopause 9(5), 329-334.
12. R.R. Freedman (2002) Core body temperature variation in symptomatic and asymptomatic postmenopausal women: Brief report. Menopause 9(6), 399-401.
13. E.W. Freeman, M.D. Sammel, L. Liu, C.R. Gracia, D.B. Nelson and L. Hollander (2004) Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of General Psychiatry 61(1), 62-70.
14. E.L. Glickman-Weiss, A.G. Nelson, C.M. Hearon, R. Prisby and N. Caine (1999) Thermal and metabolic responses of women with high fat versus low fat body composition during exposure to 5 and 27 degrees C for 120 min. Aviation Space and Environmental Medicine 70(3), 284-288. Pt 1
15. E.B. Gold, G. Block, S. Crawford, L. Lachance, G. Fitzgerald, H. Miracle, et al. (2004) Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the Study of Women's Health Across the Nation. American Journal of Epidemiology 159(12), 1189-1199.
16. D. Grady (2005) Issues related to discontinuation of menopausal hormone therapy. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms
17. K.K. Han, J.M.J. Soares, M.A. Haidar, G.R. de Lima and E.C. Baracat (2002) Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology 99(3), 389-394.
18. E. Haney (2005) Symptoms during the menopausal transition: Evidence from cohort studies. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms March 21–23, 2005, Bethesda, MD
19. S.L. Hendrix, B.B. Cochrane, I.E. Nygaard, V.L. Handa, V.M. Barnabei, C. Iglesia, et al. (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293(8), 935-948.
20. H.L. Judd, G.E. Judd, W.E. Lucas and S. Yen (1974) Endocrine function of the postmenopausal ovary: Concentration of androgens and estrogens in ovarian and peripheral vein blood. Journal of Clinical Endocrinology and Metabolism 39(6), 1020-1024.
21. D.C. Knight, J.B. Howes and J.A. Eden (1999) The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 2(2), 79-84.
22. T.B. Lebherz and L. French (1969) Nonhormonal treatment of the menopausal syndrome. A double-blind evaluation of an autonomic system stabilizer. Obstetrics and Gynecology 33(6), 795-799.
23. S. Li and K. Holm (2003) Physical activity alone and in combination with hormone replacement therapy on vasomotor symptoms in postmenopausal women. Western Journal of Nursing Research 25(3), 289-293.
24. S. Li and K. Holm (2003) Physical activity alone and in combination with hormone replacement therapy on vasomotor symptoms in postmenopausal women. Western Journal of Nursing Research 25(3), 274-288.
25. S. Li, K. Holm, M. Gulanick, D. Lanuza and S. Penckofer (1999) The relationship between physical activity and perimenopause. Health Care for Women International 20(2), 163-178.
26. J.H. Liu (2005) Therapeutic effects of progestins, androgens, and tibolene for menopausal symptoms. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms March 21–25, 2005, Bethesda, MD
27. C.L. Loprinzi (2005) Centrally active, nonhormonal hot flash therapies. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms Bethesda, MD
28. T. Low Dog (2005) Menopause: Review of botanical dietary supplement research. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms Bethesda, MD
29. L.W. Maartens, J.A. Knottnerus and V.J. Pop (2002) Menopausal transition and increased depressive symptomatology: A community based prospective study. Maturitas 42(3), 195-200.
30. K.A. Matthews and J.T. Bromberger (2005) Symptoms and health-related quality of life and the menopausal transition. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms Bethesda, MD
31. E. Nikander, A. Kilkkinen, M. Metsa-Heikkila, H. Adlercreutz, P. Pietinen, A. Tiitinen, et al. (2003) A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstetrics and Gynecology 101(6), 1213-1220.
32. M. Penotti, E. Fabio, A.B. Modena, M. Rinaldi, U. Omodei and P. Vigano (2003) Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility 79(5), 1112-1117.
33. M.H. Pittler and E. Ernst (2002) Kava extract for treating anxiety. Cochrane Database of Systematic Reviews 1 CD003383. [Update of Cochrane Database Syst Rev. 2002;(2):CD00383; PMID:12076477.]
34. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, et al. (2002) Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3), 321-333.
35. B.B. Sherwin (1998) Use of combined estrogen-androgen preparations in the postmenopause: Evidence from clinical studies. International Journal of Fertility and Women's Medicine 43(2), 98-103.
36. B.B. Sherwin (2002) Randomized clinical trials of combined estrogen-androgen preparations: Effects on sexual functioning. Fertility and Sterility 77(Suppl 4), S49-S54.
37. S.A. Shumaker, C. Shumaker, L. Shumaker, L. Kuller, S.R. Rapp, L. Thal, D.S. Lane, et al. (2004) Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in post-menopausal women: Women's Health Initiative Memory Study. JAMA 291(24), 2947-2958.
38. J. Simon, E. Klaiber, B. Wiita, A. Bowen and H.M. Yang (1999) Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in post-menopausal women. Menopause 6(2), 138-146.
39. B. Sternfeld, C.P.J. Quesenberry and G. Husson (1999) Habitual physical activity and menopausal symptoms: A case-control study. Journal of Women's Health 8(1), 115-123.
40. J.A. Tice, B. Ettinger, K. Ensrud, R. Wallace, T. Blackwell and S.R. Cummings (2003) Phytoestrogen supplements for the treatment of hot flashes: The Isoflavone Clover Extract (ICE) Study: A randomized controlled trial. JAMA 290(2), 207-214.
41. P.H. van de Weijer and R. Barentsen (2002) Isoflavones from red clover (Promensil) significantly reduce menopausal hot flash symptoms compared with placebo. Maturitas 42(3), 187-193.
42. B.J. Van Voorhis (2005) Perimenopause: Urogenital and bleeding issues. Paper presented at the NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms Bethesda, MD
43. M.K. Whiteman, C.A. Staropoli, P.W. Langenberg, R.J. McCarter, K.H. Kjerulff and J.A. Flaws (2003) Smoking, body mass, and hot flashes in midlife women. Obstetrics and Gynecology 101(2), 264-272.